Published in Curr Eye Res on November 01, 1994
Distribution of TNF alpha and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol (1996) 1.43
Involvement of Müller glial cells in epiretinal membrane formation. Graefes Arch Clin Exp Ophthalmol (2009) 1.05
Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy. Br J Ophthalmol (2001) 1.00
Nestin positive cells in adult human retina and in epiretinal membranes. Br J Ophthalmol (2003) 0.96
Mechanisms of inflammation in proliferative vitreoretinopathy: from bench to bedside. Mediators Inflamm (2012) 0.96
Differential expression of matrix metalloproteinases 2 and 9 by glial Müller cells: response to soluble and extracellular matrix-bound tumor necrosis factor-alpha. Am J Pathol (2002) 0.91
Detection of cytokine mRNA production in infiltrating cells in proliferative vitreoretinopathy using reverse transcription polymerase chain reaction. Br J Ophthalmol (1999) 0.91
Proteome Profiling of Vitreoretinal Diseases by Cluster Analysis. Proteomics Clin Appl (2008) 0.91
The role of Bcl-xL in mouse RPE cell survival. Invest Ophthalmol Vis Sci (2011) 0.81
Vitreous levels of intercellular adhesion molecule 1 (ICAM-1) as a risk indicator of proliferative vitreoretinopathy. Br J Ophthalmol (1999) 0.80
Macrophage migration inhibitory factor levels in the vitreous of patients with proliferative diabetic retinopathy. Br J Ophthalmol (2000) 0.79
The prevalence and incidence of epiretinal membranes in eyes with inactive extramacular CMV retinitis. Invest Ophthalmol Vis Sci (2014) 0.76
Human retinal pigment epithelial lysis of extracellular matrix: functional urokinase plasminogen activator receptor, collagenase, and elastase. Trans Am Ophthalmol Soc (2002) 0.76
Müller glia as an important source of cytokines and inflammatory factors present in the gliotic retina during proliferative vitreoretinopathy. Glia (2015) 0.75
Cell adhesion molecules in subretinal fluid: soluble forms of VCAM-1 (vascular cell adhesion molecule-1) and L-selectin. Int Ophthalmol (1999) 0.75
"Lymphokines": non-antibody mediators of cellular immunity generated by lymphocyte activation. Nature (1969) 6.42
Immunity in cutaneous leishmaniasis of the guinea-pig. Clin Exp Immunol (1970) 4.50
A micro-method for peripheral leucocyte migration in tuberculin sensitivity. J Clin Pathol (1971) 3.45
Experimental cutaneous leishmaniasis. 3. Effects of thymectomy on the course of infection of CBA mice with Leishmania tropica. Clin Exp Immunol (1972) 3.08
So you want to have the baby at home? CMAJ (1989) 2.31
Experimental cutaneous leishmaniasis. V. Protective immunity in subclinical and self-healing infection in the mouse. Clin Exp Immunol (1976) 2.20
Interleukin 1 in Crohn's disease. Clin Exp Immunol (1987) 2.18
Complications of retinal cryotherapy. Trans Ophthalmol Soc U K (1971) 2.17
Experimental cutaneous leishmaniasis. II. Effects of immunosuppression and antigenic competition on the course of infection with Leishmania enriettii in the guinea-pig. Clin Exp Immunol (1972) 2.15
Tissue-specific antigens. Adv Immunol (1966) 2.15
'Lymphokines': molecular mediators of cellular immune responses in animals and man. Proc R Soc Med (1970) 2.13
The role of the macrophage in delayed hypersensitivity. Br Med Bull (1967) 2.07
The clinical significance of mediators of cellular immunity. Clin Allergy (1971) 2.03
Failure in retinal detachment surgery. Br J Ophthalmol (1973) 2.02
Role of lymphocyte activation products (LAP) in cell-mediated immunity. II. Effects of lymphocyte activation products on lymph node architecture and evidence for peripheral release of LAP following antigenic stimulation. Clin Exp Immunol (1972) 1.94
Matrix metalloproteinases and their natural inhibitors in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol (2000) 1.73
PSG consensus statement on management of hepatitis C virus infection--2003. J Pak Med Assoc (2004) 1.70
Anti-retinal autoimmunity and circulating immune complexes in patients with retinal vasculitis. Lancet (1982) 1.68
Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol (2000) 1.67
In vitro studies of cell-mediated immunity. I. Induction of lymphocyte transformation by a soluble "mitogenic" factor derived from interaction of sensitized guinea-pig lymphoid cells with specific antigen. Immunology (1970) 1.60
Veno-arterial difference in alpha 1 -antitrypsin levels. Br Med J (1972) 1.59
House dust mite allergen avoidance: a randomized controlled trial of surface chemical treatment and encasement of bedding. Clin Exp Allergy (1994) 1.57
A prognostic model for prolonged event-free survival after autologous or allogeneic blood or marrow transplantation for relapsed and refractory Hodgkin's disease. Bone Marrow Transplant (2005) 1.56
HIV-1 protease processes procaspase 8 to cause mitochondrial release of cytochrome c, caspase cleavage and nuclear fragmentation. Cell Death Differ (2002) 1.54
Acute posterior vitreous detachment: the predictive value of vitreous pigment and symptomatology. Br J Ophthalmol (2000) 1.54
Lymphocyte mitogenic factor in man. Nature (1969) 1.51
Role of lymphocyte activation products (LAP) in cell-mediated immunity. I. Preparation and partial purification of guinea-pig LAP. Clin Exp Immunol (1972) 1.51
Marginal ulceration of the cornea. Br J Ophthalmol (1970) 1.49
Oral intubation in the multiply injured patient: the risk of exacerbating spinal cord damage. Ann Emerg Med (1990) 1.49
Cytokines in human intraocular inflammation. Curr Eye Res (1992) 1.44
Retinal detachment surgery. Buckling procedures and drainage of subretinal fluid. Trans Ophthalmol Soc U K (1977) 1.43
Distribution of TNF alpha and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol (1996) 1.43
Diplopia after retinal detachment surgery. Br J Ophthalmol (1987) 1.42
Computer hardware for radiologists: Part I. Indian J Radiol Imaging (2010) 1.40
Pars plana vitrectomy for the treatment of rhegmatogenous retinal detachment uncomplicated by advanced proliferative vitreoretinopathy. Br J Ophthalmol (1993) 1.40
Pneumatic balloon dilation in achalasia: a prospective comparison of balloon distention time. Am J Gastroenterol (1998) 1.39
Standardization of the leucocyte migration test. Int Arch Allergy Appl Immunol (1973) 1.39
The patient-doctor relationship. CMAJ (1990) 1.39
Band ligation vs endoscopic sclerotherapy in esophageal varices: a prospective randomized comparison. J Pak Med Assoc (1998) 1.38
Antibiotic-resistant Staphylococcus aureus in dermatology and burn wards. J Clin Pathol (1977) 1.35
Retinal detachment surgery without drainage of subretinal fluid. Am J Ophthalmol (1974) 1.31
Osteoblasts play key roles in the mechanisms of action of strontium ranelate. Br J Pharmacol (2009) 1.30
Cytokines in proliferative vitreoretinopathy. Eye (Lond) (1991) 1.26
Pulmonary complications of HIV infection: autopsy findings. Chest (1998) 1.25
Immunity to malaria. 3. Possible occurrence of a cell-mediated immunity to Plasmodium knowlesi in chronically infected and Freund's complete adjuvant-sensitized monkeys. Exp Parasitol (1970) 1.24
Experimental cutaneous leishmaniasis: VI: anergy and allergy in the cellular immune response during non-healing infection in different strains of mice. J Clin Lab Immunol (1978) 1.20
Astigmatism following retinal detachment surgery. Br J Ophthalmol (1983) 1.20
Asafoetida inhibits early events of carcinogenesis: a chemopreventive study. Life Sci (2001) 1.18
Etiology of sexually transmitted infections among street-based female sex workers in Dhaka, Bangladesh. J Clin Microbiol (2000) 1.17
Direct cleavage of the human DNA fragmentation factor-45 by granzyme B induces caspase-activated DNase release and DNA fragmentation. EMBO J (2001) 1.17
Experimental cutaneous leishmaniasis. IV. Selective suppression of cell-mediated immunity during the response of guinea-pigs to infection with Leishmania enriettii. Clin Exp Immunol (1974) 1.17
Interleukin-1 and interleukin-2 activity in chronic hepatitis B virus infection. Gastroenterology (1988) 1.15
Prophylaxis of retinal detachment. Br J Ophthalmol (1973) 1.15
Cell-mediated immunity to Varicella-Zoster antigen in acute Herpes zoster (shingles). Clin Exp Immunol (1973) 1.14
Clinical, biochemical, and immunoelectrophoretic study of subretinal fluid. Br J Ophthalmol (1971) 1.14
The Beige/Chediak-Higashi syndrome gene encodes a widely expressed cytosolic protein. J Biol Chem (1997) 1.13
Acute lower respiratory tract infection due to virus among hospitalized children in Dhaka, Bangladesh. Rev Infect Dis (1991) 1.13
A point prevalence study of 150 patients with idiopathic retinal vasculitis: 1. Diagnostic value of ophthalmological features. Br J Ophthalmol (1989) 1.12
IL-6 acts on endothelial cells to preferentially increase their adherence for lymphocytes. Clin Exp Immunol (1996) 1.11
Rituximab in combination with fludarabine chemotherapy in low-grade or follicular lymphoma. J Clin Oncol (2005) 1.11
Immunoflorescence studies of Leishmania enriettii infection in the guinea pig. Trans R Soc Trop Med Hyg (1974) 1.11
Soluble TNF receptors in vitreoretinal proliferative disease. Invest Ophthalmol Vis Sci (2001) 1.11
Peripheral leucocyte migration. Inhibited by diphtheroid organisms isolated from patients with rheumatoid arthritis. Ann Rheum Dis (1970) 1.10
Inhibition of GTP cyclohydrolase I by pterins. Biochim Biophys Acta (1988) 1.09
The production of lymphocyte mitogenic factor and migration-inhibition factor by antigen-stimulated lymphocytes of subjects with grass pollen allergy. Clin Exp Immunol (1971) 1.09
Retinal detachment surgery without cryotherapy. Br J Ophthalmol (1981) 1.08
Surgical treatment of superior bullous rhegmatogenous retinal detachments. Br J Ophthalmol (1985) 1.08
Lymphocyte transformation. Absence of increased responses in alleged halothane jaundice. JAMA (1973) 1.07
Pars plana vitrectomy for retinal detachment with unseen retinal holes. Graefes Arch Clin Exp Ophthalmol (1987) 1.07
Fluorescein angiography in anterior segment ischaemia. Br J Ophthalmol (1973) 1.06
Aphakic retinal detachment. Br J Ophthalmol (1985) 1.06
Treatment failure with the use of ciprofloxacin for gonorrhea correlates with the prevalence of fluoroquinolone-resistant Neisseria gonorrhoeae strains in Bangladesh. Clin Infect Dis (2001) 1.05
Simultaneous measurements of the accumulation of isotope-labelled protein and erythrocytes in skin reactions of allergic inflammation in the guinea-pig. Immunology (1972) 1.05
Retinal dialysis. Br J Ophthalmol (1973) 1.04
Incoming human cytomegalovirus pp65 (UL83) contained in apoptotic infected fibroblasts is cross-presented to CD8(+) T cells by dendritic cells. J Virol (2000) 1.04
Occurrence, distribution and possible sources of organochlorine pesticide residues in tropical coastal environment of India: an overview. Environ Int (2008) 1.03
Histological features of skin reactions to human lymphoid cell line lymphokine in patients with advanced cancer. J Pathol (1982) 1.03
An improved method for the purification of retinal S-antigen using selective hydrophobic adsorption chromatography. J Immunol Methods (1987) 1.02
Absorption of subretinal fluid after nondrainage retinal detachment surgery. Arch Ophthalmol (1978) 1.01
Heat shock protein peptides reactive in patients with Behçet's disease are uveitogenic in Lewis rats. Clin Exp Immunol (1994) 1.00
A longitudinal study of clinical and immunological findings in 52 patients with relapsing retinal vasculitis. Br J Ophthalmol (1988) 1.00
Endothelial cell presentation of antigen to human T cells. Hum Immunol (1981) 0.99
Iris fluorescein photography following retinal detachment and in certain ocular ischaemic disorders. Trans Ophthalmol Soc U K (1971) 0.99
A comparative trial of xenon arc and argon laser photocoagulation in the treatment of proliferative diabetic retinopathy. Br J Ophthalmol (1982) 0.99
Autoimmune mechanisms in inflammatory eye disease. Trans Ophthalmol Soc U K (1985) 0.99
Adenoviral delivery of Tousled kinase for the protection of salivary glands against ionizing radiation damage. Gene Ther (2010) 0.98
The large subunit of replication factor C is a substrate for caspase-3 in vitro and is cleaved by a caspase-3-like protease during Fas-mediated apoptosis. EMBO J (1997) 0.98
Thymus and bursa dependence of lymphocyte mitogenic factor in the chicken. Nat New Biol (1972) 0.98
Precipitins against extracts of thatched roofs in the sera of New Guinea natives with chronic lung disease. Lancet (1966) 0.97
Evaluation of the efficacy of Lawsonia alba in the alleviation of carbon tetrachloride-induced oxidative stress. J Ethnopharmacol (2000) 0.96
Experimental posterior uveitis. I: A clinical, angiographic, and pathological study. Br J Ophthalmol (1987) 0.96
Acute lower respiratory tract infections in hospitalized patients with diarrhea in Dhaka, Bangladesh. Rev Infect Dis (1991) 0.95
Semisynthetic anti-LHRH vaccine causing atrophy of the prostate. Prostate (1989) 0.95
Numerical immunotaxonomy of Leishmania. I. Differentiation of four strains of Leishmania by serological tests. Immunology (1976) 0.94
Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci (1999) 0.94